CymaBay

CymaBay Therapeutics Stumbles in NASH Race, Shares Fall
Xconomy
Tue, 06/11/19 - 10:11 am
CymaBay
NASH
clinical trials
seladelpar
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis
CP Wire
Tue, 11/13/18 - 10:26 am
CymaBay
seladelpar
primary biliary cholangitis
NASH
CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis
Tue, 11/13/18 - 10:02 am
CymaBay
seladelpar
primary biliary cholangitis
NASH
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
CP Wire
Tue, 10/30/18 - 11:22 am
CymaBay
primary biliary cholangitis
clinical trials
seladelpar
CymaBay Announces Positive Efficacy and Safety Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis
CP Wire
Wed, 04/11/18 - 11:57 pm
CymaBay
seladelpar
clinical trials